Adam assists life sciences and information technology companies navigate complex legal and business issues. With a practical and creative focus on his clients’ intended business results, he often functions as an outside general counsel and is regularly consulted by management teams for guidance on strategic matters. His clients are both public companies and emerging growth companies.
Adam has over twenty years of experience representing issuers and investment banks in connection with public and private financing transactions, SEC regulatory compliance and ’34 Act reporting. He also regularly represents buyers and sellers in mergers and acquisitions as well as corporations and limited liability companies with respect to general corporate issues that arise throughout the corporate life cycle--from formation to exit.
